Brest

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• COPD1 trial
• Polycystic kidney disease1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• GlaxoSmithKline2 trials

Running trials

• Active, not recruiting

  A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

  NCT06734234· Phase 1· GlaxoSmithKline· Source

Closed trials

• Completed

  Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

  NCT04133909· Phase 3· GlaxoSmithKline· Source